| Panelists |
Originally Published MX January/February
2002
MARKET ANALYSIS
![]() |
Christa Bähr is head of the life sciences equity research team at DZ Bank (Frankfurt, Germany), an investment banking firm that covers European life sciences companies with a special focus on German small- and midcaps. The firm focuses its research activities on the healthcare sector, paying particular attention to medical technology, biotechnology, pharmaceuticals, and agrochemicals. |
|
|
| Timothy A. Dugan is a partner at One Equity Partners (Chicago), a leading private investor in healthcare companies. The firm focuses its investment activity around medical products and devices in companies with revenues between $50 million and $500 million. |
![]() |
||
![]() |
Thomas J. Gunderson is managing director and senior research analyst for medical technology at U.S. Bancorp Piper Jaffray (Minneapolis). |
||
| Manoj Kenkare is research manager for the healthcare and life sciences practice at Frost & Sullivan (San Antonio, TX). His field of expertise is in the area of life sciences, particularly drug-discovery technologies, clinical diagnostics, medical devices, and healthcare IT. |
![]() |
||
![]() |
Joseph Kozikowski, MD, is managing partner of Proformant Inc. (Framingham, MA), a corporate-development consultancy focused on building public and private medical technology companies. His expertise is the creation of shareholder value with new medical technologies. |
||